Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Is UnitedHealth Group Stock a Millionaire Maker?: https://g.foolcdn.com/editorial/images/780725/a-couple-smiling-and-talking-with-an-advisor.jpg
Is UnitedHealth Group Stock a Millionaire Maker?

Making a million dollars from a single stock sounds like it could be an unrealistic goal. But if you pick a good growth stock, which also pays a dividend, and hold on to it for the long haul, it's

3 High-Yield Dividend Stocks Near Their 52-Week Lows to Buy and Hold: https://g.foolcdn.com/editorial/images/781093/investor-dark-room-devices-getty.jpg
3 High-Yield Dividend Stocks Near Their 52-Week Lows to Buy and Hold

Investors looking for high-yield dividend stocks to buy now should turn their attention toward the healthcare sector: Three relatively reliable drugmakers are trading near their 52-week lows.

Their

Forget Eli Lilly, Buy This Magnificent Biotech Stock Instead: https://g.foolcdn.com/editorial/images/780926/scientist-in-lab-young-african-american-female.jpg
Forget Eli Lilly, Buy This Magnificent Biotech Stock Instead

Nearly everything is going right these days for Eli Lilly (NYSE: LLY). Sales and profits have been soaring. So has the share price, jumping more than 50% year to date after a 59% gain in 2023. Lilly

Want $1,000 in Dividend Income? Here's How Much You'd Need to Invest in AT&T to Get It: https://g.foolcdn.com/editorial/images/781092/a-person-counting-money.jpg
Want $1,000 in Dividend Income? Here's How Much You'd Need to Invest in AT&T to Get It

A high-yielding stock can be a valuable asset in your portfolio because it can generate a lot of recurring income. Investors can often find great dividend stocks in the telecom sector, where

10 Stocks to Build a Dividend Portfolio That Will Pay You $1,000s per Year: https://g.foolcdn.com/editorial/images/781113/gettyimages-1720247749.jpg
10 Stocks to Build a Dividend Portfolio That Will Pay You $1,000s per Year

The power of compounding is very real. It is a process that takes time, as dividend investing is not about year 1 dividend income, but rather about year 10+. In today's video, we will look at the

Where Will Amgen Be in 5 Years?: https://g.foolcdn.com/editorial/images/780724/scientist-working-in-a-lab.jpg
Where Will Amgen Be in 5 Years?

Amgen (NASDAQ: AMGN) is a top drugmaker whose shares have risen by more than 70% in five years, which is a bit shy of the S&P 500's 90% gain over that stretch. With some promising products in its

EQS-News: MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders
EQS-News: MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders
EQS-Adhoc: Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-Adhoc: Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders
EQS-Adhoc: Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders
If You'd Invested $10,000 in AT&T Stock 20 Years Ago, Here's How Much You'd Have Today: https://g.foolcdn.com/editorial/images/781032/sad-piggy-bank-and-coins.jpg
If You'd Invested $10,000 in AT&T Stock 20 Years Ago, Here's How Much You'd Have Today

Investing in AT&T (NYSE: T) over the past two decades has delivered mixed results for long-term investors. Let's break down what a $10,000 investment in AT&T would look like today, starting in June

Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb: https://g.foolcdn.com/editorial/images/780869/high-yield.jpg
Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb

When it comes to investing in high-yield dividend stocks in the pharmaceutical space, two prominent names often come to mind: Pfizer (NYSE: PFE) and Bristol Myers Squibb (NYSE: BMY).

Both companies

EQS-News: Newron Pharmaceuticals 2024 Investor Day on June 25, 2024, in New York City: https://mms.businesswire.com/media/20200216005057/en/682845/5/logo_color_high_res.jpg
EQS-News: Newron Pharmaceuticals 2024 Investor Day on June 25, 2024, in New York City
EQS-News: Newron Pharmaceuticals 2024 Investor Day on June 25, 2024, in New York City
The Best Biotech Stock to Invest $1,000 in Right Now: https://g.foolcdn.com/editorial/images/780622/doctors-at-table.jpg
The Best Biotech Stock to Invest $1,000 in Right Now

Viking Therapeutics (NASDAQ: VKTX) is at an exciting point in its history. While it doesn't have any medicines approved for sale at the moment, it has a couple of mid-stage programs that are shaping

Better Passive Income Vehicle: AT&T vs. JPMorgan Nasdaq Equity Premium Income ETF: https://g.foolcdn.com/editorial/images/780847/passive-income-2.jpg
Better Passive Income Vehicle: AT&T vs. JPMorgan Nasdaq Equity Premium Income ETF

When it comes to generating passive income, investors have a wide range of options to choose from, including individual stocks and exchange-traded funds (ETFs). Two popular choices for

3 Top Stocks I'd Buy Today and Hold Forever Without Any Hesitation: https://g.foolcdn.com/editorial/images/779719/investors-smile-as-one-signs-a-contract.jpg
3 Top Stocks I'd Buy Today and Hold Forever Without Any Hesitation

Buying a stock with the intention of never selling it, or perhaps only selling it in a few decades, requires a level of conviction that most investments simply don't warrant. It's not enough to

 Valbiotis invited to present clinical results at the American Diabetes Association’s 84th Scientific Sessions : https://mms.businesswire.com/media/20200205005659/en/689755/5/valbiotis-logo.jpg
Valbiotis invited to present clinical results at the American Diabetes Association’s 84th Scientific Sessions
Valbiotis invited to present clinical results at the American Diabetes Association’s 84th Scientific Sessions
3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street: https://g.foolcdn.com/editorial/images/780642/cheering-person-with-laptop.jpg
3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street

Never ignore the power of momentum. Sometimes the fastest-moving objects are the ones that keep on racing ahead.

That could be the case with a select group of stocks that have delivered tremendous

Lockheed Martin Gives Thumbs Up to 1 Tiny Space Stock: https://g.foolcdn.com/editorial/images/780582/row-of-rockets-of-various-shapes-and-sizes.jpg
Lockheed Martin Gives Thumbs Up to 1 Tiny Space Stock

Valued at $110 billion and doing nearly $70 billion in annual business, Lockheed Martin (NYSE: LMT) is the world's biggest defense company. It's also a major player in space.

Lockheed Martin builds

EQS-Adhoc: Carl Zeiss Meditec AG: Revenue and EBIT forecast for fiscal year 2023/24 reduced amid slower than expected recovery of equipment businesshttp://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
EQS-Adhoc: Carl Zeiss Meditec AG: Revenue and EBIT forecast for fiscal year 2023/24 reduced amid slower than expected recovery of equipment business
EQS-Adhoc: Carl Zeiss Meditec AG: Revenue and EBIT forecast for fiscal year 2023/24 reduced amid slower than expected recovery of equipment business
EQS-News: Milestone for Biotest: US approval for innovative immunoglobulin Yimmugo: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24092/375px-Biotest_logo.svg.png
EQS-News: Milestone for Biotest: US approval for innovative immunoglobulin Yimmugo
EQS-News: Milestone for Biotest: US approval for innovative immunoglobulin Yimmugo
2 Dividend Stocks That Could Pay You for Life: https://g.foolcdn.com/editorial/images/780433/person-sitting-and-working-at-a-desk.jpg
2 Dividend Stocks That Could Pay You for Life

People invest in dividend stocks for various reasons. Some want the passive income; others reinvest the cash to boost long-term returns; still others find that corporations that can dish out regular

What Is the Dividend Payout for AT&T Stock?: https://g.foolcdn.com/editorial/images/780469/att-5g.jpg
What Is the Dividend Payout for AT&T Stock?

For many AT&T investors (NYSE: T), the dividend yield is the primary reason they own the stock.

While they like the yield, the long-term shareholders would probably rather forget about AT&T stock's

3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade: https://g.foolcdn.com/editorial/images/780482/investor-checking-stocks-getty.jpg
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade

The S&P 500 is up an incredible 25% over the past 12 months, but not every stock in the benchmark index has participated in the rally. A handful of terrific healthcare stocks have fallen more than

2 Growth Stocks Wall Street Analysts Think Can Soar by at Least 80%: https://g.foolcdn.com/editorial/images/780084/investor-looking-at-stocks-on-a-tablet.jpg
2 Growth Stocks Wall Street Analysts Think Can Soar by at Least 80%

The S&P 500 remains near record levels as the markets have been strong this year. Finding good stocks to buy in such a hot market can be challenging. But a couple of growth stocks with lots of

Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It: https://g.foolcdn.com/editorial/images/780098/a-team-of-scientists-reviewing-results-in-a-lab.jpg
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It

A business can look to be in solid shape but still not necessarily be a great investment overall. A good example of that is Viking Therapeutics (NASDAQ: VKTX). The company has been doing a lot of

3 Growth Stocks You Can Buy Right Now Without Any Hesitation: https://g.foolcdn.com/editorial/images/780514/happy-stock-investor-holding-smartphone.jpg
3 Growth Stocks You Can Buy Right Now Without Any Hesitation

Have you ever felt anxiety about clicking the final button to buy a stock? Some investors agonize over their decisions. It doesn't have to be that way, though, if you find the right stocks.

Three